FibroGen Inc
NASDAQ:FGEN
FibroGen Inc
NASDAQ:FGEN
Price:
7.99
USD
-2.08%
Market Closed
Market Cap:
$32.4m
Balance Sheet
Balance Sheet Decomposition
FibroGen Inc
FibroGen Inc
Balance Sheet Decomposition is not available for
FibroGen Inc
FibroGen Inc
Balance Sheet
FibroGen Inc
FibroGen Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
39
|
76
|
166
|
153
|
174
|
674
|
89
|
126
|
678
|
171
|
156
|
114
|
50
|
|
| Cash |
20
|
28
|
152
|
76
|
79
|
104
|
39
|
41
|
88
|
111
|
136
|
63
|
2
|
|
| Cash Equivalents |
19
|
49
|
14
|
78
|
95
|
570
|
51
|
86
|
590
|
60
|
20
|
50
|
48
|
|
| Short-Term Investments |
1
|
47
|
14
|
28
|
79
|
62
|
532
|
408
|
8
|
234
|
266
|
122
|
0
|
|
| Total Receivables |
9
|
18
|
14
|
15
|
10
|
9
|
64
|
154
|
42
|
25
|
16
|
41
|
29
|
|
| Accounts Receivables |
0
|
12
|
14
|
11
|
6
|
4
|
17
|
159
|
46
|
36
|
28
|
6
|
0
|
|
| Other Receivables |
9
|
6
|
0
|
4
|
4
|
4
|
47
|
5
|
4
|
11
|
12
|
35
|
29
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
17
|
31
|
40
|
42
|
3
|
|
| Other Current Assets |
4
|
3
|
5
|
4
|
3
|
5
|
5
|
8
|
10
|
13
|
14
|
13
|
114
|
|
| Total Current Assets |
53
|
144
|
198
|
201
|
267
|
749
|
690
|
703
|
755
|
474
|
493
|
332
|
197
|
|
| PP&E Net |
124
|
130
|
132
|
129
|
124
|
130
|
127
|
84
|
65
|
120
|
101
|
81
|
0
|
|
| PP&E Gross |
124
|
130
|
0
|
129
|
124
|
130
|
127
|
84
|
65
|
120
|
101
|
81
|
0
|
|
| Accumulated Depreciation |
33
|
38
|
0
|
48
|
54
|
60
|
65
|
112
|
134
|
132
|
153
|
174
|
2
|
|
| Long-Term Investments |
82
|
15
|
144
|
132
|
71
|
11
|
56
|
61
|
3
|
172
|
9
|
5
|
0
|
|
| Other Long-Term Assets |
8
|
8
|
9
|
9
|
8
|
10
|
8
|
10
|
4
|
8
|
7
|
5
|
18
|
|
| Total Assets |
266
N/A
|
297
+12%
|
484
+63%
|
471
-3%
|
470
0%
|
899
+91%
|
881
-2%
|
857
-3%
|
827
-4%
|
774
-6%
|
610
-21%
|
424
-31%
|
215
-49%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
3
|
1
|
5
|
7
|
6
|
6
|
9
|
6
|
25
|
26
|
31
|
18
|
5
|
|
| Accrued Liabilities |
16
|
28
|
47
|
48
|
51
|
64
|
66
|
84
|
104
|
180
|
230
|
187
|
62
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
1
|
0
|
0
|
0
|
0
|
0
|
12
|
12
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
8
|
12
|
13
|
8
|
17
|
14
|
1
|
22
|
19
|
13
|
13
|
66
|
|
| Total Current Liabilities |
24
|
38
|
63
|
67
|
65
|
86
|
89
|
103
|
163
|
226
|
274
|
218
|
133
|
|
| Long-Term Debt |
111
|
115
|
113
|
112
|
112
|
115
|
114
|
56
|
44
|
18
|
17
|
90
|
90
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
0
|
0
|
0
|
|
| Minority Interest |
28
|
28
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
20
|
20
|
42
|
42
|
|
| Other Liabilities |
9
|
37
|
67
|
94
|
117
|
150
|
149
|
164
|
169
|
292
|
321
|
278
|
175
|
|
| Total Liabilities |
171
N/A
|
217
+27%
|
262
+21%
|
293
+12%
|
314
+7%
|
370
+18%
|
371
+0%
|
341
-8%
|
405
+19%
|
565
+40%
|
632
+12%
|
628
-1%
|
440
-30%
|
|
| Equity | ||||||||||||||
| Common Stock |
305
|
305
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
248
|
263
|
322
|
408
|
470
|
631
|
716
|
785
|
974
|
1 264
|
1 558
|
1 842
|
1 889
|
|
| Additional Paid In Capital |
38
|
41
|
546
|
587
|
626
|
1 160
|
1 227
|
1 301
|
1 400
|
1 476
|
1 541
|
1 644
|
1 669
|
|
| Other Equity |
0
|
4
|
3
|
2
|
1
|
2
|
2
|
1
|
5
|
4
|
6
|
7
|
6
|
|
| Total Equity |
95
N/A
|
80
-16%
|
221
+178%
|
178
-20%
|
156
-12%
|
529
+239%
|
509
-4%
|
516
+1%
|
422
-18%
|
209
-50%
|
21
N/A
|
204
-854%
|
226
-10%
|
|
| Total Liabilities & Equity |
266
N/A
|
297
+12%
|
484
+63%
|
471
-3%
|
470
0%
|
899
+91%
|
881
-2%
|
857
-3%
|
827
-4%
|
774
-6%
|
610
-21%
|
424
-31%
|
215
-49%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
